Sanofi Drug for Rare Blood Disease Is Heading to Recordati for $825M
Sanofi’s Enjaymo, the only approved drug therapy for a rare and debilitating blood disorder, is being ...
Read more
Tag: 825M
Get the latest Health and Fitness News on YourFitnessNewsToday.com.
Wellbeing tips, weight Loss, workouts, and more...